Article Sidebar

Download
Statistic
Read Counter : 0

Downloads

Download data is not yet available.

Main Article Content

Abstract

Health care costs have continued to increase over time in patient treatment. Cost-utility analysis, a branch of pharmacoeconomic evaluation, assesses patient utility in relation to incurred costs. Chronic kidney disease (CKD) is among the most prevalent diseases in South Kalimantan; therefore, this study aimed to analyze the cost-utility of CKD patients undergoing hemodialysis. This research employed a cross-sectional design conducted in two hospitals as comparison sites, with a total of 43 participants (16 from a private hospital and 27 from a public hospital). Data were collected prospectively using the validated and reliable EQ-5D-5L questionnaire and Visual Analog Scale (VAS) to assess patient health status, along with observation sheets for cost data. The results showed that the Cost Utility Ratio (CUR) in the private hospital was Rp 78,928.88, while in the public hospital it was Rp 159,868.76, yielding an Incremental Cost Utility Ratio (ICUR) of Rp 8,626.80 per QALY. In conclusion, the private hospital demonstrated better cost-utility compared to the public hospital in providing hemodialysis treatment for CKD patients, as indicated by the ICUR value.

Keywords

Cost Utility Analysis Hemodialysis Chronic Kidney Failure Hospital

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Author Biographies

Mochammad Maulidie Alfiannor Saputera, Program Studi Sarjana Farmasi, Fakultas Farmasi, Universitas Borneo Lestari, Banjarbaru, Indonesia

Program Studi Sarjana Farmasi, Fakultas Farmasi, Universitas Borneo Lestari, Banjarbaru, Indonesia

Hasan Ismail, Program Studi Sarjana Farmasi, Fakultas Farmasi, Universitas Borneo Lestari, Banjarbaru, Indonesia

Program Studi Sarjana Farmasi, Fakultas Farmasi, Universitas Borneo Lestari, Banjarbaru, Indonesia

Didik Rio Pambudi, Program Studi Sarjana Farmasi, Fakultas Farmasi, Universitas Borneo Lestari, Banjarbaru, Indonesia

Program Studi Sarjana Farmasi, Fakultas Farmasi, Universitas Borneo Lestari, Banjarbaru, Indonesia

Aprillia Rahmadina, Program Studi Pendidikan Profesi Apoteker, Fakultas Farmasi, Universitas Borneo Lestari, Banjarbaru, Indonesia

Program Studi Pendidikan Profesi Apoteker, Fakultas Farmasi, Universitas Borneo Lestari, Banjarbaru, Indonesia

Muhamad Muslim, Program Studi Sarjana Administrasi Rumah Sakit, Fakultas Ilmu Kesehatan dan Sain Teknologi., Universitas Borneo Lestari, Banjarbaru, Indonesia

Program Studi Sarjana Administrasi Rumah Sakit, Fakultas Ilmu Kesehatan dan Sain Teknologi., Universitas Borneo Lestari, Banjarbaru, Indonesia
How to Cite
Maulidie Alfiannor Saputera, M., Ismail, H., Rio Pambudi, D., Rahmadina, A., & Muslim, M. (2025). COST UTILITY ANALYSIS PENGOBATAN HEMODIALISIS PASIEN GAGAL GINJAL KRONIK DI RUMAH SAKIT PEMERINTAH DAN SWASTA DI KALIMANTAN SELATAN. Borneo Journal of Pharmascientech, 9(2). https://doi.org/10.59053/bjp.v9i2.629
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Andayani TM, Dwi E, Susi AK, Rifki R, 2017. Metode Untuk Memeperkirakan Wllingnessto-pay Per Quality Adjusted Life Year Sebagai CostEfefectivness Threshold. Jurnal Manajemen dan Pelayanan Framasi. Vol. 7 No. 3.
  2. Cameron, J. I., & Frizzell, L. (2010). Quality of life in patients with chronic kidney disease: What is the impact of anxiety and depression? Kidney International, 77(6), 507-515.
  3. Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., & Torrance, G. W. (2005). Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press.
  4. Fauziah (2015) 'Cost of Illness Chronic Kidney Disease (CKD) dengan Tindakan Hemodialisis di Rumah Sakit Bethesda Yogyakarta', Tesis, Universitas Gadjah Mada
  5. Huang, H. H., Huang, Y. M., & Chiu, Y. H. (2010). The influence of pain on quality of life in patients with chronic kidney disease. Journal of Clinical Nursing, 19(15-16), 2301-2308.
  6. Kementerian Kesehatan RI, B. L. (2017) InfoDATIN. Jakarta.
  7. Kemenkes RI. (2018). RISET KESEHATAN DASAR. Jakarta.
  8. Nurwati R, (2018) Analisis Biaya Pengobatan Gagal Ginjal Kronik dengan Hemodialisis pada Pasien Rawat Inap di RSD Dr. Soebandi Jember Periode 2009, Pharmauho Volume 4, No. 1, April 2018, Hal. 42-47 Majalah Farmasi, Sains, dan Kesehatan ISSN 2442-9791.
  9. Olsen, J. A., & Smith, R. D. (2018). The role of cost-effectiveness analysis in health care resource allocation. Health Economics, 27(1), 3-10.
  10. Susanto Y, Riza A, Zainur R, Karani. 2018. Uji Validitas dan Reliabilitas Kuisoner EQ-5D Bahasa Indonesia Untuk Mengukur Kualitas Hidup Pasien hemodialisis Gagal Ginjal Kronik. Jurnal Ilmiah Manuntung, Volume 4, Nomer 1, Hal 41-47.
  11. Wahyuni P, Saptino M, Eka K. 2018. Hubungan Lama Menjalni Hemodialisis Dengan Kualitas Hidup Pasien Penyakit Ginjal Kronik Dengan Diabetes Melitus di RSUP Dr. M Djamil Padang. Jurnal Kesehatan Andalas, Volume 9, Nomor 4.
  12. Wong, J. M., & Zhang, W. (2016). Cost of chronic kidney disease in the United States: A systematic review. American Journal of Kidney Diseases, 67(2), 182-188.
  13. Yoshida, Y., & Ohta, M. (2013). Economic analysis of hemodialysis in patients with chronic kidney disease: A systematic review. BMC Nephrology, 14, 189.